middle.news
Mesoblast’s Ryoncil Achieves US$30.3M Q1 Sales, Nears US$100M Since Launch
1:32pm on Tuesday 7th of April, 2026 AEST
•
Healthcare
Read Story
Mesoblast’s Ryoncil Achieves US$30.3M Q1 Sales, Nears US$100M Since Launch
1:32pm on Tuesday 7th of April, 2026 AEST
Key Points
Ryoncil net sales reached US$30.3 million in Q1 2026
Total revenue since launch approaches US$100 million
Strong sales in February and March offset January seasonality
Revenue supports Mesoblast’s balance sheet and late-stage programs
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Mesoblast (ASX:MSB)
OPEN ARTICLE